Biblio
Filters: Keyword is pharmaceutical industry [Clear All Filters]
A Blockchain Framework for Ensuring Data Quality in Multi-Organizational Clinical Trials. 2019 IEEE International Conference on Healthcare Informatics (ICHI). :1–9.
.
2019. The cost and complexity of conducting multi-site clinical trials have significantly increased over time, with site monitoring, data management, and Institutional Review Board (IRB) amendments being key drivers. Trial sponsors, such as pharmaceutical companies, are also increasingly outsourcing trial management to multiple organizations. Enforcing compliance with standard operating procedures, such as preserving data privacy for human subject protection, is crucial for upholding the integrity of a study and its findings. Current efforts to ensure quality of data collected at multiple sites and by multiple organizations lack a secure, trusted, and efficient framework for fragmented data capture. To address this challenge, we propose a novel data management infrastructure based on a permissioned blockchain with private channels, smart contracts, and distributed ledgers. We use an example multi-organizational clinical trial to design and implement a blockchain network: generate activity-specific private channels to segregate data flow for confidentiality, write channel-specific smart contracts to enforce regulatory guidelines, monitor the immutable transaction log to detect protocol breach, and auto-generate audit trail. Through comprehensive experimental study, we demonstrate that our system handles high-throughput transactions, exhibits low-latency, and constitutes a trusted, scalable solution.
Traceability of Counterfeit Medicine Supply Chain through Blockchain. 2019 11th International Conference on Communication Systems Networks (COMSNETS). :568–570.
.
2019. The main issues with drug safety in the counterfeit medicine supply chain, are to do with how the drugs are initially manufactured. The traceability of right and active pharmaceutical ingredients during actual manufacture is a difficult process, so detecting drugs that do not contain the intended active ingredients can ultimately lead to end-consumer patient harm or even death. Blockchain's advanced features make it capable of providing a basis for complete traceability of drugs, from manufacturer to end consumer, and the ability to identify counterfeit-drug. This paper aims to address the issue of drug safety using Blockchain and encrypted QR(quick response) code security.